|
1.
|
Fidler IJ and Poste G: The ‘seed and soil’
hypothesis revisited. Lancet Oncol. 9:8082008.
|
|
2.
|
Poste G and Fidler IJ: The pathogenesis of
cancer metastasis. Nature. 283:139–146. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Paget S: The distribution of secondary
growths in cancer of the breast. Lancet. 133:571–573. 1889.
View Article : Google Scholar
|
|
4.
|
Albini A and Sporn MB: The tumour
microenvironment as a target for chemoprevention. Nat Rev Cancer.
7:139–147. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Zhang W, Remenyik E, Zelterman D, Brash DE
and Wikonkal NM: Escaping the stem cell compartment: sustained UVB
exposure allows p53-mutant keratinocytes to colonize adjacent
epidermal proliferating units without incurring additional
mutations. Proc Natl Acad Sci USA. 98:13948–13953. 2001. View Article : Google Scholar
|
|
6.
|
Karnoub AE, Dash AB, Vo AP, et al:
Mesenchymal stem cells within tumour stroma promote breast cancer
metastasis. Nature. 449:557–563. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
El-Haibi CP and Karnoub AE: Mesenchymal
stem cells in the pathogenesis and therapy of breast cancer. J
Mammary Gland Biol Neoplasia. 15:399–409. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Lin TM, Chang HW, Wang KH, et al:
Isolation and identification of mesenchymal stem cells from human
lipoma tissue. Biochem Biophys Res Commun. 361:883–889. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Houghton J, Stoicov C, Nomura S, et al:
Gastric cancer originating from bone marrow-derived cells. Science.
306:1568–1571. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Gibbs CP, Kukekov VG, Reith JD, et al:
Stem-like cells in bone sarcomas: implications for tumorigenesis.
Neoplasia. 7:967–976. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Kang SG, Shinojima N, Hossain A, et al:
Isolation and perivascular localization of mesenchymal stem cells
from mouse brain. Neurosurgery. 67:711–720. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Kim SM, Kang SG, Park NR, et al: Presence
of glioma stroma mesenchymal stem cells in a murine orthotopic
glioma model. Childs Nerv Syst. 27:911–922. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Kim YG, Jeon S, Sin GY, et al: Existence
of glioma stroma mesenchymal stem-like cells in Korean glioma
specimens. Childs Nerv Syst. Dec 29–2012.(Epub ahead of print).
View Article : Google Scholar
|
|
14.
|
Dominici M, Le Blanc K, Mueller I, et al:
Minimal criteria for defining multipotent mesenchymal stromal
cells. The International Society for Cellular Therapy position
statement. Cytotherapy. 8:315–317. 2006. View Article : Google Scholar
|
|
15.
|
Kucerova L, Matuskova M, Hlubinova K,
Altanerova V and Altaner C: Tumor cell behaviour modulation by
mesenchymal stromal cells. Mol Cancer. 9:1292010. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Shin GY, Shim JK, Lee JH, et al: Changes
in the biological characteristics of glioma cancer stem cells after
serial in vivo subtransplantation. Childs Nerv Syst. 29:55–64.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Dirks PB: Brain tumor stem cells: bringing
order to the chaos of brain cancer. J Clin Oncol. 26:2916–2924.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Galli R, Binda E, Orfanelli U, et al:
Isolation and characterization of tumorigenic, stem-like neural
precursors from human glioblastoma. Cancer Res. 64:7011–7021. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Singh SK, Hawkins C, Clarke ID, et al:
Identification of human brain tumour initiating cells. Nature.
432:396–401. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Sulman E, Aldape K and Colman H: Brain
tumor stem cells. Curr Probl Cancer. 32:124–142. 2008. View Article : Google Scholar
|
|
21.
|
Yuan X, Curtin J, Xiong Y, et al:
Isolation of cancer stem cells from adult glioblastoma multiforme.
Oncogene. 23:9392–9400. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Kong BH, Park NR, Shim JK, et al:
Isolation of glioma cancer stem cells in relation to histological
grades in glioma specimens. Childs Nerv Syst. 29:217–219. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Louis DN, Ohgaki H, Wiestler OD, et al:
The 2007 WHO classification of tumours of the central nervous
system. Acta Neuropathol. 114:97–109. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Singh SK, Clarke ID, Terasaki M, et al:
Identification of a cancer stem cell in human brain tumors. Cancer
Res. 63:5821–5828. 2003.PubMed/NCBI
|
|
25.
|
Lal S, Lacroix M, Tofilon P, Fuller GN,
Sawaya R and Lang FF: An implantable guide-screw system for brain
tumor studies in small animals. J Neurosurg. 92:326–333. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Nam DH, Park K, Park C, et al:
Intracranial inhibition of glioma cell growth by cyclooxygenase-2
inhibitor celecoxib. Oncol Rep. 11:263–268. 2004.PubMed/NCBI
|
|
27.
|
Kang SG, Kim JS, Park K, Kim JS, Groves MD
and Nam DH: Combination of celecoxib and temozolomide in C6 rat
glioma orthotopic model. Oncol Rep. 15:7–13. 2006.PubMed/NCBI
|
|
28.
|
Kim SJ, Uehara H, Karashima T, Shepherd
DL, Killion JJ and Fidler IJ: Blockade of epidermal growth factor
receptor signaling in tumor cells and tumor-associated endothelial
cells for therapy of androgen-independent human prostate cancer
growing in the bone of nude mice. Clin Cancer Res. 9:1200–1210.
2003.
|
|
29.
|
Qiao L, Xu Z, Zhao T, et al: Suppression
of tumorigenesis by human mesenchymal stem cells in a hepatoma
model. Cell Res. 18:500–507. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Khakoo AY, Pati S, Anderson SA, et al:
Human mesenchymal stem cells exert potent antitumorigenic effects
in a model of Kaposi’s sarcoma. J Exp Med. 203:1235–1247.
2006.PubMed/NCBI
|
|
31.
|
Ohlsson LB, Varas L, Kjellman C, Edvardsen
K and Lindvall M: Mesenchymal progenitor cell-mediated inhibition
of tumor growth in vivo and in vitro in gelatin matrix. Exp Mol
Pathol. 75:248–255. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Nakamura K, Ito Y, Kawano Y, et al:
Antitumor effect of genetically engineered mesenchymal stem cells
in a rat glioma model. Gene Ther. 11:1155–1164. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Roorda BD, ter Elst A, Kamps WA and de
Bont ES: Bone marrow-derived cells and tumor growth: contribution
of bone marrow-derived cells to tumor micro-environments with
special focus on mesenchymal stem cells. Crit Rev Oncol Hematol.
69:187–198. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Djouad F, Plence P, Bony C, et al:
Immunosuppressive effect of mesenchymal stem cells favors tumor
growth in allogeneic animals. Blood. 102:3837–3844. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Le Blanc K and Ringden O: Immunobiology of
human mesenchymal stem cells and future use in hematopoietic stem
cell transplantation. Biol Blood Marrow Transplant. 11:321–334.
2005.PubMed/NCBI
|
|
36.
|
Zhu W, Xu W, Jiang R, et al: Mesenchymal
stem cells derived from bone marrow favor tumor cell growth in
vivo. Exp Mol Pathol. 80:267–274. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Ramasamy R, Lam EW, Soeiro I, Tisato V,
Bonnet D and Dazzi F: Mesenchymal stem cells inhibit proliferation
and apoptosis of tumor cells: impact on in vivo tumor growth.
Leukemia. 21:304–310. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Wang X, Zhang Z and Yao C: Survivin is
upregulated in myeloma cell lines cocultured with mesenchymal stem
cells. Leuk Res. 34:1325–1329. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39.
|
Patel SA, Meyer JR, Greco SJ, Corcoran KE,
Bryan M and Rameshwar P: Mesenchymal stem cells protect breast
cancer cells through regulatory T cells: role of mesenchymal stem
cell-derived TGF-beta. J Immunol. 184:5885–5894. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40.
|
Konopleva M, Konoplev S, Hu W, Zaritskey
AY, Afanasiev BV and Andreeff M: Stromal cells prevent apoptosis of
AML cells by up-regulation of anti-apoptotic proteins. Leukemia.
16:1713–1724. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
41.
|
Shinagawa K, Kitadai Y, Tanaka M, et al:
Mesenchymal stem cells enhance growth and metastasis of colon
cancer. Int J Cancer. 127:2323–2333. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
42.
|
Lin YM, Zhang GZ, Leng ZX, et al: Study on
the bone marrow mesenchymal stem cells induced drug resistance in
the U937 cells and its mechanism. Chin Med J (Engl). 119:905–910.
2006.PubMed/NCBI
|
|
43.
|
Kurtova AV, Balakrishnan K, Chen R, et al:
Diverse marrow stromal cells protect CLL cells from spontaneous and
drug-induced apoptosis: development of a reliable and reproducible
system to assess stromal cell adhesion-mediated drug resistance.
Blood. 114:4441–4450. 2009. View Article : Google Scholar
|
|
44.
|
Vianello F, Villanova F, Tisato V, et al:
Bone marrow mesenchymal stromal cells non-selectively protect
chronic myeloid leukemia cells from imatinib-induced apoptosis via
the CXCR4/CXCL12 axis. Haematologica. 95:1081–1089. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
45.
|
Sasser AK, Mundy BL, Smith KM, et al:
Human bone marrow stromal cells enhance breast cancer cell growth
rates in a cell line-dependent manner when evaluated in 3D tumor
environments. Cancer Lett. 254:255–264. 2007. View Article : Google Scholar
|
|
46.
|
Zhang W: Mesenchymal stem cells in cancer:
friends or foes. Cancer Biol Ther. 7:252–254. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
47.
|
Haniffa MA, Wang XN, Holtick U, et al:
Adult human fibroblasts are potent immunoregulatory cells and
functionally equivalent to mesenchymal stem cells. J Immunol.
179:1595–1604. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
48.
|
Paunescu V BF, Tatu CA, Gavriliuc OI,
Rosca A, Gruia AT, Tanasie G, Bunu C, Crisnic D, Gherghiceanu M,
Tatu FR, Tatu CS and Vermesan S: Tumour-associated fibroblasts and
mesenchymal stem cells: more similarities than differences. J Cell
Mol Med. 15:635–646. 2011.PubMed/NCBI
|
|
49.
|
Spaeth EL, Dembinski JL, Sasser AK, et al:
Mesenchymal stem cell transition to tumor-associated fibroblasts
contributes to fibrovascular network expansion and tumor
progression. PLoS One. 4:e49922009. View Article : Google Scholar : PubMed/NCBI
|
|
50.
|
Mishra PJ, Humeniuk R, Medina DJ, et al:
Carcinoma-associated fibroblast-like differentiation of human
mesenchymal stem cells. Cancer Res. 68:4331–4339. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
51.
|
Hall B, Dembinski J, Sasser AK, Studeny M,
Andreeff M and Marini F: Mesenchymal stem cells in cancer:
tumor-associated fibroblasts and cell-based delivery vehicles. Int
J Hematol. 86:8–16. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
52.
|
Brentnall TA, Lai LA, Coleman J, Bronner
MP, Pan S and Chen R: Arousal of cancer-associated stroma:
overexpression of palladin activates fibroblasts to promote tumor
invasion. PLoS One. 7:e302192012. View Article : Google Scholar : PubMed/NCBI
|
|
53.
|
Zhi K, Shen X, Zhang H and Bi J:
Cancer-associated fibroblasts are positively correlated with
metastatic potential of human gastric cancers. J Exp Clin Cancer
Res. 29:662010. View Article : Google Scholar : PubMed/NCBI
|
|
54.
|
Liao D, Luo Y, Markowitz D, Xiang R and
Reisfeld RA: Cancer associated fibroblasts promote tumor growth and
metastasis by modulating the tumor immune microenvironment in a 4T1
murine breast cancer model. PLoS One. 4:e79652009. View Article : Google Scholar : PubMed/NCBI
|
|
55.
|
Casey TM, Eneman J, Crocker A, et al:
Cancer associated fibroblasts stimulated by transforming growth
factor beta1 (TGF-beta 1) increase invasion rate of tumor cells: a
population study. Breast Cancer Res Treat. 110:39–49. 2008.
View Article : Google Scholar
|
|
56.
|
Ostman A and Augsten M: Cancer-associated
fibroblasts and tumor growth - bystanders turning into key players.
Curr Opin Genet Dev. 19:67–73. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
57.
|
Honczarenko M, Le Y, Swierkowski M, Ghiran
I, Glodek AM and Silberstein LE: Human bone marrow stromal cells
express a distinct set of biologically functional chemokine
receptors. Stem Cells. 24:1030–1041. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
58.
|
Gilbertson RJ and Rich JN: Making a
tumour’s bed: glioblastoma stem cells and the vascular niche. Nat
Rev Cancer. 7:733–736. 2007.
|
|
59.
|
Ciavarella S, Dominici M, Dammacco F and
Silvestris F: Mesenchymal stem cells: a new promise in anticancer
therapy. Stem Cells Dev. 20:1–10. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
60.
|
Dai LJ, Moniri MR, Zeng ZR, Zhou JX, Rayat
J and Warnock GL: Potential implications of mesenchymal stem cells
in cancer therapy. Cancer Lett. 305:8–20. 2011. View Article : Google Scholar : PubMed/NCBI
|
